Nambour Skin Cancer Prevention Trial

ATBC, Alpha Tocopherol Beta Carotene Prevention Study CARET, Beta Carotene and Retinol Efficacy Trial HPS, Heart Protection Study LCPS, Linxian Cancer Prevention Study NSCPT, Nambour Skin Cancer Prevention Trial PHS, Physicians Health Study VACP, Vitamin A and Cancer Preventbn WHS, Women s Health Study CVD, Cardio Vascular disease. 

A number of trials have attempted to investigate the effect of yS-carotene supplementation on nonmelanoma skin cancer, the most common forms of which are basal cell and squamous cell carcinomas (these types of cells are both found in the top layer of the skin). However, none have shown any significant effect on skin cancer prevention. For example, the Physicians Health Study found no effect after 12 years of yS-carotene supplementation on the development of a first nomnelanoma skin cancer. The Nambour Skin Cancer Prevention Trial of 1621 men and women followed for nearly 5 years (most of whom had no history of skin cancer at baseline) showed that those supplemented with 30 mg yd-car-otene did not experience any reduction in risk of basal cell or squamous cell carcinoma or the occurrence of solar keratoses (precancerous skin growths that are a strong determinant of squamous cell... 

---

See also in sourсe #XX -- [ ]

---